- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Evidence-Based Tack Drives HF Guidelines
An update to guidelines for managing heart failure emphasizes evidence-based therapy, according to the document from the American College of Cardiology (ACC) and the American Heart Association.
In particular, the authors introduced a new designation for optimal treatment called guideline-directed medical therapy (GDMT).
"This important 'call-out' of GDMT should be especially helpful for primary care physicians and physician extenders involved in the care of patients with heart failure," noted writing committee chair Clyde Yancy, MD, chief of cardiology at Northwestern University Feinberg School of Medicine in Chicago, in a statement.
Read the full story here: http://bit.ly/16PB9Ft
Source: Med Page Today
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Intermountain Healthcare and Story Health Partner to Optimize Rural Heart Failure Care
February 7th 2023On this episode of Managed Care Cast, we speak with Tom Stanis, CEO and cofounder of Story Health, and Phillip Wood, Intermountain Ventures program director, on how their partnership came about, how it is going so far, and the future of their collaboration.
Listen
Midodrine Use Linked to Decrease in HFrEF-Related ED Visits
March 23rd 2024However, researchers saw higher risks of respiratory failure, longer stays in the intensive care unit, increased hospitalizations, and elevated mortality rates in patients with heart failure with reduced ejection fraction (HFrEF) taking the antihypotensive medication.
Read More
